Shopping Cart
- Remove All
Your shopping cart is currently empty
TCS PrP Inhibitor 13 (5-(4-Nitrophenyl)-2-Phenyl-4H-Pyrazol-3-One) is an antiprion agent inhibiting protease-resistant prion protein (PrP-res) accumulation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $32 | In Stock | |
| 10 mg | $53 | In Stock | |
| 25 mg | $107 | In Stock | |
| 50 mg | $167 | In Stock | |
| 100 mg | $257 | In Stock | |
| 200 mg | $366 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $34 | In Stock |
| Description | TCS PrP Inhibitor 13 (5-(4-Nitrophenyl)-2-Phenyl-4H-Pyrazol-3-One) is an antiprion agent inhibiting protease-resistant prion protein (PrP-res) accumulation. |
| Targets&IC50 | PrPC:3 nM (in ScN2a and F3 cells) |
| In vitro | In Schwannoma cells, administration of 0-500 μM TCS PrP Inhibitor 13 reduces levels of total ERK1/2, pAKT, total FAK, Cyclin D1, PrPC and increases expression of cleaved caspase-3 significantly. TCS PrP Inhibitor 13 also significantly reduces the number of proliferating, Ki67-positive cells and total cell number in Schwannoma cells[2]. |
| Synonyms | 5-(4-Nitrophenyl)-2-Phenyl-4H-Pyrazol-3-One |
| Molecular Weight | 281.27 |
| Formula | C15H11N3O3 |
| Cas No. | 34320-83-7 |
| Smiles | [O-][N+](=O)c1ccc(cc1)C1=NN(C(=O)C1)c1ccccc1 |
| Relative Density. | 1.38g/cm3 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 88 mg/mL (312.87 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.73 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.